Ukko

About Ukko

Ukko is a biopharmaceutical company focused on developing allergy immunotherapies using computational protein design and AI to re-educate the immune system. The company designs versions of allergens that do not trigger a harmful response but promote immune tolerance, aiming to treat life-threatening allergies. Based in the United States, Ukko targets severe food allergies and gluten-related disorders with a dedicated research and development program.